+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment eligibility rates for chronic hepatitis C infection among US veterans in Brooklyn

Treatment eligibility rates for chronic hepatitis C infection among US veterans in Brooklyn

Hepatology 32(4 Pt 2): 589A, October

(PDF 0-2 workdays service: $29.90)

Accession: 035980147

Download citation: RISBibTeXText

Related references

A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. Journal of Clinical Gastroenterology 34(3): 268-271, 2002

Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection. Clinical Therapeutics 39(1): 130-137, 2016

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. American Journal of Gastroenterology 100(8): 1772-1779, 2005

Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment. American Journal on Addictions 20(4): 312-318, 2011

Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings. Journal of Clinical Gastroenterology 49(2): 145-149, 2015

Epidemiology of hepatitis C infection and eligibility for antiviral therapy among US veterans. Hepatology 38(4 Suppl 1): 452A, October, 2003

Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. Digestive Diseases and Sciences 61(2): 618-625, 2016

Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?. Journal of Clinical Gastroenterology 41(2): 199-205, 2007

Increased eligibility for treatment of chronic hepatitis C infection with shortened duration of therapy: Implications for access to care and elimination strategies in Canada. Canadian Journal of Gastroenterology & Hepatology 29(3): 125-129, 2016

Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs. Epidemiologic Reviews 37: 131-143, 2015

Chronic pain treatment and health service utilization of veterans with hepatitis C virus infection. Pain Medicine 13(11): 1407-1416, 2013

Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009. Plos One 10(7): E0132056-E0132056, 2016

A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans. Aids Research and Human Retroviruses 27(9): 973-979, 2011

Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection. Annals of PharmacoTherapy: 1060028018766507-1060028018766507, 2018

Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics 37(2): 243-251, 2013